The inflamed immune phenotype [300], high PD-L1 expression via AI evaluation [301], and higher number of TILs predicted by CT radiomics [222] have been associated with better response to immunotherapy, while other serum tumor markers, such as CYFRA and CEA, predicted poor response with very high specificity [302]. This evidence concerns the gene CEACAM5 and neoplasm.